Frequency Therapeutics, Inc(NASDAQ:FREQ) 
Frequency Therapeutics, Inc., a clinical-stage biotechnology company, focuses on harnessing the body's innate biology to repair or reverse damage caused by a range of degenerative diseases. Its Progenitor Cell Activation approach, uses combinations of small molecules to activate progenitor cells wit...
Website: http://www.frequencytx.com
IPO Price: $14 (Oct 03, 2019)
Full Time Employees: 43
CEO: David L. Lucchino
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-05-09
P
O 0.39
H 0.40
L 0.38
C 0.39
V 138,575
10EMA 0.39
20EMA 0.39
60EMA 0.39
120EMA 0.39
250EMA 0.39